QURE
uniQure N.V. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website uniqure.com
- Employees(FY) 501
- ISIN NL0010696654
Performance
-1.18%
1W
+6.6%
1M
-14.36%
3M
-22.08%
6M
-26.0%
YTD
-75.63%
1Y
Profile
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Technical Analysis of QURE 2024-05-10
Overview:
In analyzing the technical indicators for QURE over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide your invest...
Recent News & Updates
- 2023-10-05 01:49
Why Shares of uniQure Are Up Thursday(Yahoo Finance)
- 2023-10-04 20:15
- 2023-10-04 19:19
UniQure to lay off about 20% of workforce(Yahoo Finance)
- 2023-10-04 19:05
- 2023-10-01 19:05
- 2023-09-05 01:10
Why Shares of uniQure Are Dropping Tuesday(Yahoo Finance)
- 2023-09-04 19:05
- 2023-09-01 06:51
- 2023-08-31 10:12
11 Cheap Small-Cap Stocks to Buy Before the Next Breakout(Yahoo Finance)
- 2023-08-26 03:51
3 Tantalizing Stocks to Buy for Under $10(Yahoo Finance)
- 2023-08-05 20:05
- 2023-07-31 21:05
UniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates(Yahoo Finance)
- 2023-07-31 19:54
UniQure: Q2 Earnings Snapshot(Yahoo Finance)
- 2023-07-31 19:05
- 2023-07-27 08:35
- 2023-06-27 21:20
FDA Accepts Pfizer's (PFE) Hemophilia B Gene Therapy Filing(Yahoo Finance)
- 2023-06-27 18:02
- 2023-06-25 19:11
- 2023-06-22 03:03
Why uniQure Stock Cratered This Week(Yahoo Finance)
- 2023-06-21 22:17
- 2023-06-21 08:00
QURE: Lowering target price to $13.00(Yahoo Finance)
- 2023-06-21 04:08
- 2023-06-20 23:46
Why uniQure Stock Is Crashing Today(Yahoo Finance)
- 2023-06-20 19:05
- 2023-06-19 19:05
- 2023-06-19 19:00
- 2023-06-15 19:05
- 2023-05-14 19:53
- 2023-05-14 19:05
- 2023-05-13 20:16